Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Chevalier

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Heart (British Cardiac Society)|August 12, 2016
Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patientsGian Battista Danzi, Raffaele Piccolo, Bernard Chevalier, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 22, 2017
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?Andrew K Roy, Bernard Chevalier, Thierry Lefèvre, et al.
JACC. Cardiovascular Imaging|July 24, 2017
Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular ScaffoldsCarlos Collet, Bernard Chevalier, Angel Cequier, et al.
European Heart Journal. Cardiovascular Imaging|March 23, 2017
Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudyYoshinobu Onuma, Carlos Collet, Robert-Jan van Geuns, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 26, 2016
Comparison of Transradial vs Transfemoral Access for Aortoiliac and Femoropopliteal Interventions: A Single-Center ExperienceAndrew K Roy, Phillipe Garot, Yves Louvard, et al.
JACC. Cardiovascular Interventions|November 21, 2015
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)Yuki Ishibashi, Shimpei Nakatani, Yohei Sotomi, et al.
International Journal of Cardiovascular Interventions|December 10, 2002
Clinical and angiographic results with the NIR stent: First International NIR Endovascular Stent Study (FINESS-II)Wolfgang Rutsch, Ferdinand Kiemeneij, Antonio Colombo, et al.
Journal of the American College of Cardiology|February 20, 2016
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-UpPatrick W Serruys, John Ormiston, Robert-Jan van Geuns, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2Bernard Chevalier, Sigmund Silber, Seung-Jung Park, et al.
Heart (British Cardiac Society)|January 11, 2022
Outcomes and regional differences in practice in a worldwide coronary stent registryMurat Cimci, Jawed Polad, Mamas Mamas, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Heart (British Cardiac Society)|August 12, 2016
Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patientsGian Battista Danzi, Raffaele Piccolo, Bernard Chevalier, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 22, 2017
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?Andrew K Roy, Bernard Chevalier, Thierry Lefèvre, et al.
JACC. Cardiovascular Imaging|July 24, 2017
Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular ScaffoldsCarlos Collet, Bernard Chevalier, Angel Cequier, et al.
European Heart Journal. Cardiovascular Imaging|March 23, 2017
Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudyYoshinobu Onuma, Carlos Collet, Robert-Jan van Geuns, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 26, 2016
Comparison of Transradial vs Transfemoral Access for Aortoiliac and Femoropopliteal Interventions: A Single-Center ExperienceAndrew K Roy, Phillipe Garot, Yves Louvard, et al.
JACC. Cardiovascular Interventions|November 21, 2015
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)Yuki Ishibashi, Shimpei Nakatani, Yohei Sotomi, et al.
International Journal of Cardiovascular Interventions|December 10, 2002
Clinical and angiographic results with the NIR stent: First International NIR Endovascular Stent Study (FINESS-II)Wolfgang Rutsch, Ferdinand Kiemeneij, Antonio Colombo, et al.
Journal of the American College of Cardiology|February 20, 2016
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-UpPatrick W Serruys, John Ormiston, Robert-Jan van Geuns, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2Bernard Chevalier, Sigmund Silber, Seung-Jung Park, et al.
Heart (British Cardiac Society)|January 11, 2022
Outcomes and regional differences in practice in a worldwide coronary stent registryMurat Cimci, Jawed Polad, Mamas Mamas, et al.
Pageof 21